Remgro, the investment heavyweight chaired and controlled by Johann Rupert, has signalled that most of its investee companies are on the recovery path, though private hospital operator Mediclinic is still feeling pandemic-related pressure.

Remgro, which holds about 45% of Mediclinic, said in a trading update headline earnings per share from continuing operations are expected to rise at least 60% in its year to end-June. ..

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.